Altimmune Inc (ALT)
Healthcare
Biotechnology
3.00 $
+5.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Altimmune Inc (ALT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -68 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -8.5 | -3.2 | 202 | -20 | -9.4 | -9.6 | -34 | -78 | -63 | -76 | -80 | -68 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.4 | 0.3 | 0.6 | 0.5 | 0.5 | 0.2 | 0.1 | |
| 1.7 | 0.6 | 2.2 | 1.4 | 0.8 | 1.3 | 2.6 | 5.5 | 8.1 | 11 | 14 | 16 | |
| 1.3 | 0.3 | 3.3 | 35 | 19 | 8.7 | 19 | 19 | 8.2 | – | – | – | |
| 0.0 | -0.5 | 4.2 | -11 | 7.0 | 1.8 | -4.5 | -0.3 | 14 | -8.3 | 4.5 | 6.8 | |
| 0.1 | 0.1 | 0.0 | 0.2 | 1.0 | 0.0 | 0.3 | 12 | 0.1 | 0.0 | 0.0 | 0.0 | |
| -0.1 | -0.1 | -67 | 14 | -1.0 | -28 | -72 | 88 | -73 | 14 | -28 | -132 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3,791 | 135 | – | – | – | – | – | |
| 19 | 1.0 | 3.8 | 13 | -2.4 | 3,791 | 135 | 224 | -0.5 | 0.2 | 0.3 | 0.3 | |
| -2.1 | -0.8 | -0.1 | 2.8 | -1.5 | -0.3 | – | 0.0 | – | – | 0.0 | 35 | |
| 17 | 0.2 | 3.8 | 16 | 32 | 13 | 213 | 65 | 57 | 86 | 10 | 207 | |
| 8.2 | -3.1 | 138 | 9.4 | 22 | -25 | 107 | 74 | -79 | 24 | -98 | 6.8 | |
| -8.6 | -3.3 | 201 | -20 | -10 | -9.6 | -35 | -91 | -63 | -76 | -80 | -68 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.